ArticleMolecular medicine (Cambridge, Mass.)2026
Visceral and subcutaneous adipose stem cells modulate colorectal cancer cell progression: direct and indirect contact distinctly accelerate tumor aggressiveness.
Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAdipose tissue is increasingly recognized as an important component of the tumor microenvironment of colorectal cancer (CRC) and actively contributes to the progression of the disease. Adipose stem cells (ASCs), one of its key constituents, can interact with cancer cells and contribute to tumorigenic processes. However, there is a poor understanding of the underlying basis of ASC-mediated support in the progression of CRC. METHODOLOGY: In this study, we employed direct and indirect co-culture models to investigate interactions between ASCs and colorectal cancer cells. The study was performed using human visceral ASCs (V-ASCs) and subcutaneous ASCs (S-ASCs), along with three colorectal cancer cell lines. The analyses primarily focused on the characteristics of CRC cell progression in 2D and 3D conditions. Cell proliferation and migration after indirect co-culture were assessed using video microscopy, XTT assay, wound healing, and spontaneous migration assay. Corresponding measurements for direct co-culture were performed using high-throughput confocal microscopy. Changes in the epithelial-mesenchymal transition (EMT) such as the phenotype and stemness features were evaluated by confocal microscopy imaging, while gene and protein expression were analyzed using qRT-PCR and Western blotting. Additional analyses were conducted using cells cultured in spheroid models with both indirect and direct cell-cell interaction to assess the spheroid formation capacity, phenotypic characteristics, and the ability of cells to migrate out of the spheroids.
resultsThe results demonstrate that paracrine interaction with ASCs results in increased migration and proliferation of CRC cells accompanied by EMT-related transcriptional and phenotypic changes and reduced levels of stemness-associated molecules. Notably, direct contact with ASCs potentiated these effects, which suggests more aggressive behavior of the CRC cells. The spheroid assays showed increases in spheroid formation and dispersal capacity of CRC cells with ASCs present under direct co-culture conditions. The findings indicate that both S-ASCs and V-ASCs were associated with comparable changes in CRC cell behavior, despite originating from distinct fat depots.
conclusionsThe results suggest a potential role of ASCs in modulating the plasticity of CRC cells and specific aspects of aggressive behavior, including increased growth and motility, as well as an association with loss of stemness features through distinct interactions that affect tumor progression. This study indicates that targeting physical interactions may be a relevant complement to strategies focused on paracrine signaling within the tumor microenvironment in the development of new therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.